White blood cell DNA adducts in a cohort of asthmatic children exposed to environmental tobacco smoke by Wilson, Stephen E. et al.
ORIGINAL ARTICLE
White blood cell DNA adducts in a cohort of asthmatic children
exposed to environmental tobacco smoke
Stephen E. Wilson • Glenn Talaska • Robert S. Kahn •
Brenda Schumann • Jane Khoury • Anthony C. Leonard •
Bruce P. Lanphear
Received: 3 November 2009/Accepted: 9 March 2010/Published online: 25 March 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract
Purpose Exposuretoenvironmentaltobaccosmoke(ETS)
leads to molecular damage in the form of DNA adducts.
While lung cancer risk is higher among African Americans
compared to White Americans, a few studies have tested for
racial differences in DNA adducts among children exposed
to ETS. The purpose of this study was to test whether
African American children have higher DNA adducts levels
compared to White children adjusted for ETS exposure.
Methods Data and biologic specimens were drawn from
an existing cohort of 212 asthmatic children. These sub-
jects participated in a 12-month ETS-reduction trial that
employed HEPA air cleaners with active ﬁlter cartridges
and sham ﬁlter cartridges. White blood cell (WBC) DNA
was analyzed for DNA adducts using
32P-postlabeling. We
assessed ETS exposure using a validated air nicotine
dosimeter. We determined the independent relationship
between African American race and DNA adduct levels
adjusted for ETS exposure and air cleaner use.
Results The mean age of the subjects was 8.4 years;
55% were African American. There was no difference in
DNA adduct levels between African American and White
children (11.8 vs. 11.2 adducts per 10
9 nucleotides,
p = 0.86), despite slightly higher levels of air nicotine
exposure (3.4 vs. 2.2 lg/m
3, p = 0.14). African American
children used their air cleaners less often than White
children. We found that the best predictor of DNA adduct
levels was the duration of air cleaner use (r =- 0.133,
p = 0.056). This association was independent of cartridge
type.
Conclusions We did not see differences in adduct levels
by race even after accounting for the level of ETS expo-
sure. However, there was a marginal inverse association
between air cleaner use and adducts. Additional research is
required to understand this phenomenon.
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Environmental tobacco smoke (ETS) is a widespread tox-
icant linked to approximately 4,000 cancer deaths per year
in the US (United States, Public Health Service, Ofﬁce of
the Surgeon General 2006). ETS contains over 4,000
chemicals and 60 known carcinogens (IARC Working
Group 2004). Polycyclic aromatic compounds (PAC) are a
group of carcinogens found in ETS. When inhaled, these
compounds are activated by phase I enzymes and can bind
to DNA bases to form bulky products known as DNA
adducts. DNA adducts can lead to mutations, which may
disrupt normal cellular function and initiate carcinogenesis.
Among active smokers, individuals with higher adduct
levels have an increased risk of developing lung cancer
(Whyatt et al. 2000; Tang et al. 2001; Veglia et al. 2003).
In addition, individuals who began smoking earlier in life
have a higher disease rate; this is independent of whether
they continue to smoke or stop smoking (Wiencke et al.
1999). Among adults who have never smoked, DNA
adduct levels are associated strongly with the development
of lung cancer (Peluso et al. 2005). Children appear par-
ticularly susceptible to the genotoxic effects of ETS.
Studies of mother–infant dyads have found higher DNA
adduct levels in the newborns compared to the mothers
despite a lower estimated exposure to ETS (Whyatt et al.
2001; Perera et al. 2004).
As with many diseases, tobacco-related disorders are
not equally distributed in humans. Despite lower levels of
tobacco use, African American smokers suffer higher
rates of lung cancer compared with White smokers
(United States Department of Heath and Human Services
1998; Haiman et al. 2006). Even among lifetime non-
smokers, African American women have a signiﬁcantly
higher lung cancer incidence than White women (Thun
et al. 2006, 2008). These studies raise questions as to
whether certain populations are more susceptible to the
carcinogenic effects of tobacco or sustain exposures in
excess of other groups. Weiserbs et al. reported a twofold
higher level of DNA adducts among African Americans
compared to White Americans and Latino Americans
(Weiserbs et al. 2003). Among smokers, African Ameri-
cans have higher cotinine levels (nicotine metabolite)
than Whites (Caraballo et al. 1998; Benowitz et al. 1999,
2004; Ahijevych et al. 2002). There are also striking
racial differences in cotinine among ETS-exposed chil-
dren. In previous work, we demonstrated that African
American children had higher levels of cotinine in their
serum and hair than White children, despite similar levels
of ETS exposure (Wilson et al. 2005, 2007). However, a
few studies have tested for racial differences in DNA
adducts among children adjusting carefully for ETS
exposure.
The factors that result in higher levels of ETS exposure
within families are complex and not completely under-
stood. Housing size and ventilation are known to impact
children’s exposure to ETS, as measured by serum cotinine
(Henschen et al. 1997; Wilson et al. 2005). We conducted a
study to determine whether equipping the homes of asth-
matic children with high-efﬁciency particulate arrestor
(HEPA) air cleaning devices would have a positive impact
on reducing exposure to ETS. We tested for differences in
white blood cell (WBC) DNA adduct levels between White
and African-American children, initially since the literature
suggested that such a racial difference may be expected,
but also because an effect was indicated in our own pre-
liminary data with a subset of the participants.
Methods
Data for this study were drawn from the Cincinnati Asthma
Prevention Study (CAP Study) (NCT00006565). The gen-
eral methods used in that study have been previously
described (Wilson et al. 2005, 2007; Spanier et al. 2006;
Yolton et al. 2008). The CAP Study was a year-long, double
blinded, placebo-controlled trial that aimed to test the efﬁ-
cacy of reducing ETS exposure among children with asthma
using HEPA air cleaners. Each study participant received 2
HEPA air cleaners with either active or placebo cartridges.
One air cleaner was placed in the main activity room
while the other was placed in the child’s bedroom. The
objective of the current study was to test for differences in
WBC PAC-DNA adducts while accounting for the level of
ETS exposure. We measured adduct levels in leukocytes
from whole blood samples collected at the 12-month visit
of the study. In addition, we collected urine samples at
the 6-month visit of the study and measured levels of
1-hydroxypyrene (1-HP). Primary variables of interest
included parent-reported race and household air nicotine. In
addition, we assessed ETS exposure by measuring cotinine
levels in serum and hair. This study was approved by the
Cincinnati Children’s Hospital Medical Center Institutional
Review Board (Human Subjects Protection Committee).
Study population
The study cohort consisted of a bi-racial community-based
sample (55% African American) of environmental
tobacco-exposed children (N = 225) with asthma. We
collected whole blood specimens from 212 study partici-
pants. Children were eligible for the parent study if they
fulﬁlled the following criteria: ages 5–12 years old; phy-
sician-diagnosed asthma; exposure to[5 cigarettes per day
in or around the home; no coexisting lung disease, heart
disease or neuromuscular disease.
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We assessed ETS exposure in the home by measuring air
nicotine using nicotine dosimeters. The dosimeters used in
thisstudyconsistofaﬁltertreated withsodiumbisulfateand
contained in a 4-cm polystyrene cassette. Nicotine passively
diffuses to the dosimeter and is collected on the ﬁlter. The
dosimeter was placed in a standard, unobstructed location
within the main activity room of each housing unit. This
room was designate by the primary caregiver as the location
where family members spent most of their non-sleeping
hours. Dosimeters were placed at baseline and 6 months of
the study and subsequently retrieved at 6 and 12 months,
respectively. Forthis study,we usedthe dosimetermeasures
from6to12 months.Thenicotinedosimeterswereanalyzed
in Dr Katherine Hammond’s laboratory at University of
California at Berkeley using a standardized protocol
(Marbury et al. 1993; Hammond et al. 1995; Glasgow et al.
1998; Eisner et al. 2001). Nicotine was extracted from
the ﬁlter using an ethanol solution. Sodium hydroxide
was added to the solution to adjust the pH, and the solution
was subsequently analyzed by gas chromatography. Nico-
tine levels were reported in micrograms/ﬁlter. The passive
monitors have a limit of detection of 0.01 lg/ﬁlter
(0.01 lg/m
3) (Hammond et al. 1995; Eisner et al. 2001).
Race
For this study, we assessed race by surveying the primary
caregiver. The primary caregiver of each subject was asked
to select their child’s race (African American or Black,
White, Asian or Asian American, Asian Indian, Native
American, Native Hawaiian/Paciﬁc Islander, Middle East-
ern) and ethnicity (Hispanic or Non-Hispanic). Because the
cohort was primarily African American and White (95%),
weexcludedotherracialandethnicgroupsforthepurposeof
thisanalysis.Parentswereinstructedtoselectasmanyofthe
categoriesastheydeemedappropriate.Becausetherewerea
few subjects in other racial and ethnic categories, only those
children reported to be African American or White were
included in our analysis. Children who were described as
African American and White were categorized as mixed-
race subjects (n = 8). We performed a sensitivity analysis
with mixed-race subjects included with African American
subjects and then with White subjects to determine whether
therewereanydifferences.Sincethemixed-raceindividuals
had no impact on the ﬁnal results, we included them with
African Americans as we have done in our previous studies.
Cotinine
In addition to air nicotine, we assessed ETS exposure by
measuring cotinine levels in children’s serum and hair.
We collected serum and hair samples at baseline, 6 and
12 months of the study. Serum cotinine, a short-term
measure of tobacco smoke exposure, has a half-life of 15–
25 h and reﬂects tobacco exposure in the prior 3–4 days.
Serum samples were analyzed at the CDC’s National
Center for Environmental Health using a well-validated
protocol (Bernert et al. 1997, 2000; United States
Department of Heath and Human Services 1998; Muscat
et al. 2002; Ahijevych and Garrett 2004). Brieﬂy, serum
samples were analyzed for cotinine using high perfor-
mance liquid chromatography (HPLC) linked to atmo-
spheric-pressure chemical ionization tandem mass
spectrometry. Trichloroacetic acid was added to each
specimen followed by potassium hydroxide to neutralize
this mixture. Cotinine was extracted using methylene
chloride and subsequently injected into the HPLC column.
Cotinine was monitored in the eluant by mass spectrom-
etry (limit of detection = 0.05 ng/ml). Hair cotinine levels
provided estimates of ETS exposure in the previous
3 months. Hair samples from the occipital scalp were
transported to the Division of Clinical Pharmacology at
the University of Toronto and analyzed using a well-val-
idated procedure (Knight et al. 1996; Klein and Koren
1999). These hair samples were washed and dried with a
mild detergent. Cotinine was extracted from the hair using
sodium hydroxide. This solution was neutralized using
hydrochloric acid. Cotinine concentrations were deter-
mined using radioimmunoassay as previously described in
the literature (Eliopoulos et al. 1994; Klein and Koren
1999). Hair cotinine values were reported in nanograms
(ng) of cotinine per milligram (mg) of hair with a limit of
detection of 0.005 ng/mg.
DNA adducts
We analyzed PAC-DNA adducts in white blood cells using
a
32P-postlabeling technique.
32P-postlabeling is a very
sensitive method that does not require that the identity of
the agent be known a priori. With this technique, we have
been able to detect carcinogen–DNA adducts at levels of
0.01–0.1 adducts/10
8 nucleotides using as little as 100 pmol
of DNA. The samples are
32P-postlabeled with an excess of
[
32P]ATP and allow calculation of the relative adduct level
(RAL).
RAL ¼
cpmadducts
1:25   106=pmolATP   3240pmol dNP=lgDNAÞ lgDNA ðÞ

  109
Int Arch Occup Environ Health (2011) 84:19–27 21
123where lg DNA is the amount of DNA in the speciﬁc
sample.
Frozen samples were stored at -80C until analysis.
Blood samples were rapidly thawed in warm water and
centrifuged to collect the WBC. The pellet was resus-
pended in 1 ml of 1% SDS, 10 mM EDTA and frozen
(-80C) until the DNA was isolated. DNA was isolated
using the common enzyme–solvent method where ribonu-
cleic acids and proteins are degraded and the latter
extracted into an organic phase while the former remains in
solution when DNA is precipitated in ethanol. DNA was
resolubilized in a small volume (10–20 ll) of 0.01 Sorenson’s
sodium citrate. We digested DNA to 30-phosphodeoxynu-
cleosides using 2.5 lg calf spleen phosphodiesterase and
0.25 U micrococcal endonuclease. We added Nuclease P1
to the mixture to enhance kinase selection of adducted
monophosphates. Samples were labeled with 250 lCi [
32P]
ATP per sample. Subsequently, we spotted 5–20 ll of the
32P-labeled sample onto polyethyleneimine-modiﬁed (PEI)
cellulose sheets and placed them in the liquid chromatog-
raphy chamber. Adduct levels were measured using auto-
radiography on the chromatograms (Talaska et al. 1990,
1991a, b; Reichert and French 1994). All samples were
analyzed in duplicate at least. A positive control (DNA
from animals exposed to benzo(a)pyrene) was analyzed
with every sample run.
1-Hydroxypyrene
We collected urine specimens at the 6-month study visit
and assayed them for 1-HP using a standardized method
(Jongeneelen et al. 1988). Urinary 1-HP was analyzed by
high performance liquid chromatography (HPLC) (Waters
680 Automated Gradient Controller; and reverse phase
column 10 cm 9 4 mm I.D.) with ﬂuorescence detection
(Waters 730 Data Module), after enzymatic hydrolysis.
The mobile phase used was methanol–water at a ﬂow rate
of 1 ml/min. The excitation wavelength of the ﬂuorescence
detector for 1-HP was set to 242 nm and the emission
wavelength to 388 nm. Creatinine was measured in urine
samples using a creatinine kit (Stanbio Direct Creatinine
LiquiColor Procedure No. 0420) and a spectrophotometer
(Beckman Coulter DU800). All values are reported in ng/g
of creatinine.
Variables of interest
We collected extensive measures of household character-
istics and parental smoking habits during each study visit.
First, we assessed the size of the home. We calculated the
dimensions of each room using an electronic tape measure.
Then, we totaled the volume of the rooms to obtain an
overall home volume. In addition, we surveyed the primary
caregiver about the number of cigarettes smoked around
the child per day. We asked the primary caregiver to
estimate the number of hours per day that the child was in
the same room as a smoker. Each HEPA unit was equipped
with a counter to document hours of air cleaner use. We
documented total hours of use for the entire study period.
Lastly, we collected information on asthma-related
healthcare utilization and asthma medication use in the
previous 3 months. Realizing that time of year can have an
impact on these factors, we also documented the season of
the year (winter, spring, fall summer) when the home visit
occurred.
Statistical analysis
We tested for differences in predictors and outcomes using
parametric and non-parametric tests as appropriate. We
estimated the means and variances for continuous variables
and the frequencies and proportions for categorical vari-
ables. Since the distributions of air nicotine, serum coti-
nine, hair cotinine, urine 1-HP and DNA adducts were
highly skewed, we log-transformed these data prior to any
analysis. We tested for racial differences in PAC-DNA
adducts, air nicotine, urine 1-HP, serum cotinine and hair
cotinine using t-tests. Differences in health care utilization
were tested using the wilcoxon rank sum test. In our
sample, there were 117 children identiﬁed as African
American and 95 identiﬁed as White. Assuming a two-
tailed alpha = 0.05 and power of 0.8, we estimated the
ability to detect a difference in adduct levels of 0.34
adducts per 10
8 nucleotides. The
32P-postlabeling tech-
nique has a limit of detection of 0.01–0.1 adducts per 10
8
nucleotides (Reichert and French 1994; Talaska et al. 1995,
2002). Thus, the effect size is well above our limit of
detection.
Using the Pearson correlations, we tested for signiﬁcant
associations between DNA adducts and markers of ETS
exposure (air nicotine, serum cotinine and hair cotinine).
Also, we tested for associations between air cleaner use and
asthma severity—as measured by health care utilization
and asthma medication use. Since air nicotine levels are not
impacted by metabolism, we use it as our primary measure
of ETS exposure. Since the urine samples were collected at
6 months and 1-HP levels represent recent exposure to
PACs, we did not test for associations between 1-HP and
other markers of ETS exposure, which were collected at
the 12-month visit. To determine the independent rela-
tionship between African American race and DNA adducts,
we constructed a multivariable linear regression model
with DNA adducts as the outcome. Since these data were
drawn from a randomized trial, we tested for differences in
DNA adduct levels by group assignment (active vs. pla-
cebo). All analyses were conducted in SAS 9.1 (Cary, NC).
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We measured DNA adduct levels in whole blood samples
of 212 participants in the Cincinnati Asthma Prevention
Study. The mean age of the children in the sample was
8.4 years. Of the participants, 55% were African American
and 37% were women. There were no signiﬁcant racial
differences in age, gender or health care utilization. We
examined factors that might impact DNA adduct levels.
We found that African American children lived in smaller
homes with marginally higher air nicotine levels than
White children (3.4 vs. 2.2 lg/m
3, p = 0.145) (Table 1).
On the other hand, African American children were
exposed to fewer hours of active smoking per day than
White children, but this difference was also not statistically
signiﬁcant. On average, households with White children
used the air cleaners more often than those with African
American children (6795 vs. 5530 h, p\0.001). However,
we did not ﬁnd an association between air cleaner use and
health care utilization or asthma treatment (data not
shown). While air cleaner use was marginally associated
with DNA adduct levels (p =- 0.133, p = 0.056), there
were no differences in DNA adducts between children with
active and control ﬁlter cartridges (11.6 vs. 11.5 adducts
per 10
9 nucleotides, p = 0.97).
Consistent with previous studies, we noted that African
American children had higher levels of both serum and hair
cotinine compared to White children. Despite differences
in cotinine, we found no signiﬁcant racial differences in
DNA adduct levels. African American and White children
had similar levels of DNA (11.8 vs. 11.2 adducts per 10
9
nucleotides, p = 0.86). Also, we found no signiﬁcant racial
differences in urine levels of 1-HP. We tested for
associations between DNA adducts and markers of ETS
exposure. First, we tested for a relationship between air
nicotine and biologic measures of cotinine and found sig-
niﬁcant associations (Table 2). However, we found no
statistically signiﬁcant associations between DNA adducts
and either hair or serum cotinine. In addition, there was no
association between DNA adducts and integrated air nic-
otine levels.
Subsequently, we used multivariable modeling to test
for independent associations between DNA adducts and
other variables of interest (Table 3). We included air nic-
otine as the objective marker of ETS exposure, since it is
not impacted by metabolic differences. Still, there were no
differences in DNA adducts by race or sex after accounting
of ETS exposure, home volume or age. While air cleaner
use was marginally signiﬁcant in the bivariate model, it
was not signiﬁcantly associated with DNA adduct levels in
the multivariable model.
Discussion
We report that overall air cleaner use was marginally
associated with DNA adduct levels regardless of the child’s
race or sex. This ﬁnding is interesting particularly since it
was independent of whether or not the air cleaner contained
an active HEPA unit. There are at least two potential
explanations for these data. It could be that the majority of
carcinogens in ETS that can be detected in blood lym-
phocytes are not bound to particles but remain in the vapor
phase. Vapor phase carcinogens would not be ﬁltered by
the HEPA ﬁlters in the units. This possibility is consistent
with our ﬁnding that the air levels of nicotine, a vapor
Table 1 Demographic characteristics and biomarker levels by race
African American (N = 117) White American (N = 95) p-Value
Age (years) (SD) 8.8 (1.8) 8.4 (1.8) 0.127
Women (%) 40.2 35.8 0.51
Cigarettes smoked around the home per day (cigs/day) (SD) 10.4 (9.1) 17.0 (12.2) \0.001
Home volume (m
3) (SD) 209.5 (78.2) 240.3 (104.6) 0.018
Health care utilization (mean ± SD)*
,? 0.45 (0.74) 0.61 (1.10) 0.57
Reported inhaled steroid use (%) 22.5 27.1 0.44
Smoking in the same room (h/day)** 0.75 (0.42–1.1) 1.2 (0.7–1.6) 0.148
Air cleaner use (h) (SD) 5,530 (2,800) 6,794 (2,968) \0.001
Air nicotine (lg/m
3) (95% CI) 3.4 (2.4–4.7) 2.2 (1.4–3.6) 0.145
Serum cotinine (ng/ml) (95% CI) 1.4 (1.1–1.9) 0.83 (0.6–1.1) 0.011
Hair cotinine (ng/mg) (95% CI) 0.28(0.24–0.34) 0.07 (0.06–0.1) \0.001
Urine 1-HP (ng/g creatinine) (95% CI) 27.7 (20.3–37.8) 32.5 (24.3–43.5) 0.457
DNA adducts (per 10
9 nucleotides) 11.9 (7.4–19.0) 11.2 (6.8–18.4) 0.863
Data presented as %, * mean (SD) and ** geometric mean (95% CI)
? Health care utilization deﬁned as unscheduled clinic visit, emergency department visit or hospitalization
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Prior studies have demonstrated an association between
housing size and ventilation, and other markers of tobacco
smoke exposure (Henschen et al. 1997; Wilson et al. 2005).
However, there is another plausible explanation. It is pos-
sible that since the air cleaners had to be turned off and on
by the parent that increased time of air cleaner usage may
also be surrogate indicator of unmeasured behavior chan-
ges within the family that resulted in lower exposure to
ETS among the children.
While we conﬁrmed racial differences in both hair and
serum cotinine, we did not ﬁnd signiﬁcant racial differ-
ences in DNA adducts. The absence of a difference in DNA
adducts was surprising, given that African American chil-
dren were exposed to marginally higher levels of ETS
compared to White children and used their air cleaners less.
Our results differ from other studies that have reported
racial differences in DNA adducts. In Weiserbs’ cohort
study, the authors reported that African American smokers
had WBC DNA adduct levels that exceeded both White
and Hispanic smokers by twofold, even after accounting
for current smoking levels and lifetime tobacco use
(Weiserbs et al. 2003). Wang et al. also reported striking
racial differences in DNA adducts in a cohort of non-
smoking women, but in the opposite direction (Wang et al.
2008). The authors recruited subjects from New York City
(primarily African American and Dominican) and Krakow
Poland (European) and tested for racial differences in DNA
adducts. DNA adducts in European women exceeded those
of African American women by twofold. However, expo-
sure to air pollution was substantially higher among
European women compared to African American women.
In contrast, another study reported no racial difference in
DNA adducts among smokers. In a case–control study of
African American and Mexican American lung cancer
patients, Vulimiri et al. found striking racial differences in
DNA adducts among cancer patients (Vulimiri et al. 2000).
Mexican American subjects (n = 37) had aromatic DNA
adduct levels that were 38% higher than African American
subjects (n = 6), but there were no signiﬁcant racial dif-
ferences in DNA adduct levels among the control subjects.
TheabsenceofaracialdifferencesinDNAadductsinthis
cohort is surprising. It has been documented in previous
studies thatAfricanAmerican smokers suffer higher rates of
lung cancer when compared with White smokers, despite
lower reported levels of tobacco use (United States
Department of Heath and Human Services 1998; United
States, Public Health Service, Ofﬁce of the Surgeon General
2006). Certainly, Haiman et al. demonstrated higher lung
cancer rates among African Americans compared with all
other racial and ethnic groups (Haiman et al. 2006). This
phenomenon has also been observed among lifetime
Table 2 Correlation
coefﬁcients between DNA
adduct levels and other
variables of interest
Data presented as r (p-value)
and N. Associations with a
p-value\0.05 are highlighted
in bold
DNA
adducts
Air
cleaner
use
Cigarettes
smoked around
the home
Air
nicotine
Serum
cotinine
Hair
cotinine
DNA adducts 1.0 -0.133 0.016 -0.044 0.055 0.028
0.0563 0.8188 0.533 0.4259 0.6989
208 205 205 212 197
Air cleaner use 1.0 0.044 -0.008 -0.152 -0.217
0.5343 0.9067 0.0282 0.0025
201 202 208 193
Cigarettes smoked around the home 1.0 0.326 0.323 -0.030
<0.0001 <0.0001 0.6784
198 205 190
Air nicotine 1.0 0.645 0.275
<0.0001 0.0001
205 190
Serum cotinine 1.0 0.478
<0.0001
197
Hair cotinine 1.0
Table 3 Multivariable regression model for DNA adducts
Variable of interest B coefﬁcient p-Value
Air nicotine -0.029 0.76
African American race 0.277 0.458
Home volume (per m
3) -0.0007 0.727
Smoking in room with child (per hour) -0.038 0.679
Air cleaner use -0.0001 0.1034
Age 0.085 0.408
Women -0.405 0.268
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Cohort identiﬁed an increased risk of lung cancer mortality
among African American women when compared with
White women (HR = 1.43, CI = 1.11–1.85) (Thun et al.
2006). Given that DNA adducts are associated with the
development of lung tumors, it is plausible that African
Americans would have higher adduct levels (Tang et al.
2001; Peluso et al. 2005). However, our data do not support
this hypothesis. There are some possible explanations for
ourﬁndings.First,wemeasuredadductsinasurrogatetissue
(WBCs) rather than the target tissue (lung). Thus, the WBC
DNA adducts may not represent the aggregate amount of
tobacco-induced damage occurring in the lungs. Moreover,
WBCs may represent a surrogate for other exposures in
adults that are not experienced by children, to the same
extent. Thus, these exposures could be associated with a
smoking lifestyle. In addition, our cohort consisted solely of
non-smoking children; studies of racial differences in lung
cancer have focused primarily on smoking adults, and may
be racial differences in DNA adducts occur only among
active smokers. Lastly, the absence of racial differences in
1-Hydroxypyrene could indicate that there may have been
unmeasured sources of PACs in our study.
Our results are subject to some limitations. First, our
study was cross-sectional in design. At best, we could only
identify an association between adducts and tobacco smoke
exposure. Second, air nicotine levels were only measured
in the main activity room of the home. Thus, there may
have been unmeasured exposures in other parts of the home
or outside of the home that contributed to adduct forma-
tion. Thus, parents may have smoked around their child in
other parts of the home that would not have been captured
by the nicotine dosimeter. In addition, we were unable to
determine the impact of the air cleaners on PACs—com-
pounds likely leading to adduct formation—as airborne
levels of these compounds were not directly measured.
Unfortunately, urine 1-HP levels cannot differentiate
inhaled versus ingested exposure to PACs, and 1-HP levels
reﬂect only recent exposure to PAC materials. While we
did measure serum and hair cotinine levels that would
capture ETS exposures outside of the home, it is well
known that these biomarkers differ signiﬁcantly by race.
Still, we did not ﬁnd any association of WBC DNA adducts
with serum cotinine or hair cotinine—which operate as
aggregate biomarkers of exposure. Third, we only mea-
sured PAC-DNA adducts, which may represent only a
fraction of DNA damage induced by tobacco smoke.
Aromatic amines are another family of compounds found
in ETS that can form adducts with DNA (Talaska et al.
1991a, b; Hecht 2001, 2004). Fourth, there may have been
sources of PACs other than ETS—such as exhaust from
automobiles or dietary intake—that were not measured by
the air nicotine dosimeters. Exposure to automobile
exhaust and consumption of charbroiled foods have both
been linked to higher PAC-DNA adduct levels (Rothman
et al. 1993; Perera et al. 2005). Lastly, all of the subjects in
this study had asthma. It is unknown whether these results
are generalizable to children without asthma.
Despite the results, our study did employ some unique
strategies. We assembled a bi-racial cohort of tobacco-
exposed children with asthma, which allowed us to explore
factors that might contribute to DNA damage. While other
studies have used ELISA tests, we used
32P-postlabeling
with nuclease P1 enhancement to measure DNA adducts in
our study sample. This process allowed for the detection of
very low levels of PAC-DNA adducts (0.01 adducts per 10
9
nucleotides) without prior knowledge of the identity of the
compounds (Reddy et al. 1981; Reddy and Randerath
1986). We assessed ETS exposure in the home using a
validated air nicotine dosimeter. The dosimeters provided
an objective measurement of the child’s in-home exposure
to ETS for 6 months prior to the measurement of the
DNA adducts. To our knowledge, this is the ﬁrst study
to attempt to correlate air nicotine levels with DNA
adducts in a cohort of ETS-exposed children with asthma.
Also, we demonstrated a non-signiﬁcant trend toward an
inverse relationship between air cleaner use and DNA
adduct levels. Even though there were no differences in
adduct levels between subjects with active and control
ﬁlters, it is notable that increased use of the air cleaner
trended toward lower DNA adduct levels. Potentially,
improved room ventilation may reduce DNA adduct levels.
Further studies are required to conﬁrm and extend these
ﬁndings.
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